Autocrine activation of canonical BMP signaling regulates PD-L1 and PD-L2 expression in human dendritic cells

European Journal of Immunology

Volumn 44, Issue 4, 2014, Pages 1031-1038

  Martínez, Víctor G ^a   Hidalgo, Laura ^a   Valencia, Jaris ^a   Hernández López, Carmen ^a   Entrena, Ana ^a   del Amo, Beatriz G ^a   Zapata, Agustín G ^a   Vicente, Angeles ^a   Sacedón, Rosa ^a   Varas, Alberto ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Bone morphogenetic proteins; Dendritic cells; Dorsomorphin; PD L1; PD L2

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; CYTOKINE; INTERFERON REGULATORY FACTOR 1; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2;

ARTICLE; AUTOCRINE EFFECT; CELL MATURATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOTHERAPY; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

BONE MORPHOGENETIC PROTEINS; DENDRITIC CELLS; DORSOMORPHIN; PD-L1; PD-L2;

ANTIGENS, CD274; AUTOCRINE COMMUNICATION; BONE MORPHOGENETIC PROTEIN 4; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INTERFERON REGULATORY FACTOR-1; KILLER CELLS, NATURAL; MONOCYTES; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84897989971     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343693     Document Type: Article

References (36)

1. Miyazono, K., Kamiya, Y. and Morikawa, M., Bone morphogenetic protein receptors and signal transduction. J. Biochem. 2010. 147: 35-51.
2. Sieber, C., Kopf, J., Hiepen, C. and Knaus, P., Recent advances in BMP receptor signaling. Cytokine. Growth. Factor. Rev. 2009. 20: 343-355.
3. Reddi, A. H., BMPs: from bone morphogenetic proteins to body morphogenetic proteins. Cytokine Growth Factor Rev. 2005. 16: 249-250.
4. Varas, A., Hager-Theodorides, A. L., Sacedon, R., Vicente, A., Zapata, A. G. and Crompton, T., The role of morphogens in T-cell development. Trends Immunol. 2003. 24: 197-206.
5. Kersten, C., Dosen, G., Myklebust, J. H., Sivertsen, E. A., Hystad, M. E., Smeland, E. B. and Rian, E., BMP-6 inhibits human bone marrow B lymphopoiesis-upregulation of Id1 and Id3. Exp. Hematol. 2006. 34: 72-81.
6. Hager-Theodorides, A. L., Outram, S. V., Shah, D. K., Sacedon, R., Shrimpton, R. E., Vicente, A., Varas, A. and Crompton, T., Bone morphogenetic protein 2/4 signaling regulates early thymocyte differentiation. J. Immunol. 2002. 169: 5496-5504.
7. Hidalgo, L., Martinez, V. G., Valencia, J., Hernandez-Lopez, C., Vazquez, M. N., Nunez, J. R., Zapata, A. G. et al., Expression of BMPRIA on human thymic NK cell precursors: role of BMP signaling in intrathymic NK cell development. Blood 2012. 119: 1861-1871.
8. Varas, A., Sacedon, R., Hidalgo, L., Martinez, V. G., Valencia, J., Cejalvo, T., Zapata, A. et al., Interplay between BMP4 and IL-7 in human intrathymic precursor cells. Cell. Cycle 2009. 8: 4119-4126.
9. Sivertsen, E. A., Huse, K., Hystad, M. E., Kersten, C., Smeland, E. B. and Myklebust, J. H., Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells. Eur. J. Immunol. 2007. 37: 2937-2948.
10. Yoshioka, Y., Ono, M., Osaki, M., Konishi, I. and Sakaguchi, S., Differential effects of inhibition of bone morphogenic protein (BMP) signalling on T-cell activation and differentiation. Eur. J. Immunol. 2012. 42: 749-759.
11. Cunningham, N. S., Paralkar, V. and Reddi, A. H., Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc. Natl. Acad. Sci. USA 1992. 89: 11740-11744.
12. Perron, J. C. and Dodd, J., ActRIIA and BMPRII Type II BMP receptor subunits selectively required for Smad4-independent BMP7-evoked chemotaxis. PLoS. One 2009. 4: e8198.
13. Hong, J. H., Lee, G. T., Lee, J. H., Kwon, S. J., Park, S. H., Kim, S. J. and Kim, I. Y., Effect of bone morphogenetic protein-6 on macrophages. Immunology 2009. 128: e442-e450.
14. Lee, G. T., Jung, Y. S., Lee, J. H., Kim, W. J. and Kim, I. Y., Bone morphogenetic protein 6-induced interleukin-1beta expression in macrophages requires PU.1/Smad1 interaction. Mol. Immunol. 2011. 48: 1540-1547.
15. Martinez, V. G., Hernandez-Lopez, C., Valencia, J., Hidalgo, L., Entrena, A., Zapata, A. G., Vicente, A. et al., The canonical BMP signaling pathway is involved in human monocyte-derived dendritic cell maturation. Immunol. Cell Biol. 2011. 89: 610-618.
16. Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J. and Enk, A. H., Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997. 27: 3135-3142.
17. Sabado, R. L. and Bhardwaj, N., Directing dendritic cell immunotherapy towards successful cancer treatment. Immunotherapy 2010. 2: 37-56.
18. Omar, O. M., Graneli, C., Ekstrom, K., Karlsson, C., Johansson, A., Lausmaa, J., Wexell, C. L. and Thomsen, P., The stimulation of an osteogenic response by classical monocyte activation. Biomaterials 2011. 32: 8190-8204.
19. Arikawa, T., Omura, K. and Morita, I., Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J. Cell Physiol. 2004. 200: 400-406.
20. Fukui, N., Zhu, Y., Maloney, W. J., Clohisy, J. and Sandell, L. J., Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J. Bone. Joint. Surg. Am. 2003. 85-A(Suppl 3): 59-66.
21. Yang, X., Fullerton, D. A., Su, X., Ao, L., Cleveland, J. C., Jr. and Meng, X., Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J. Am. Coll. Cardiol. 2009. 53: 491-500.
22. Breton, G., Yassine-Diab, B., Cohn, L., Boulassel, M. R., Routy, J. P., Sekaly, R. P. and Steinman, R. M., siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals. J. Clin. Immunol. 2009. 29: 637-645.
23. Karakhanova, S., Meisel, S., Ring, S., Mahnke, K. and Enk, A. H., ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets. Eur. J. Immunol. 2010. 40: 254-266.
24. Hubo, M., Trinschek, B., Kryczanowsky, F., Tuettenberg, A., Steinbrink, K. and Jonuleit, H., Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front. Immunol. 2013. 4: 82.
25. Keir, M. E., Francisco, L. M. and Sharpe, A. H., PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 2007. 19: 309-314.
26. Abe, M., Wang, Z., de Creus, A. and Thomson, A. W., Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 2005. 5: 1808-1819.
27. Shen, T., Chen, X., Chen, Y., Xu, Q., Lu, F. and Liu, S., Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection. J. Med. Virol. 82: 1152-1159.
28. Barreira da Silva, R. and Munz, C., Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals. Cell. Mol. Life Sci. 2011. 68: 3505-3518.
29. Alvarez, I. B., Pasquinelli, V., Jurado, J. O., Abbate, E., Musella, R. M., de la Barrera, S. S. and Garcia, V. E., Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. J. Infect. Dis. 2010. 202: 524-532.
30. Benson, D. M., Jr., Bakan, C. E., Mishra, A., Hofmeister, C. C., Efebera, Y., Becknell, B., Baiocchi, R. A. et al., The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. Blood. 2010. 116: 2286-2294.
31. Gabriele, L. and Ozato, K., The role of the interferon regulatory factor (IRF) family in dendritic cell development and function. Cytokine Growth Factor Rev. 2007. 18: 503-510.
32. Tailor, P., Tamura, T. and Ozato, K., IRF family proteins and type I interferon induction in dendritic cells. Cell. Res. 2006. 16: 134-140.
33. Lee, S. J., Jang, B. C., Lee, S. W., Yang, Y. I., Suh, S. I., Park, Y. M., Oh, S. et al., Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS Lett. 2006. 580: 755-762.
34. Torabi-Rahvar, M., Bozorgmehr, M., Jeddi-Tehrani, M. and Zarnani, A. H., Potentiation strategies of dendritic cell-based antitumor vaccines: combinational therapy takes the front seat. Drug Discov. Today 2011. 16: 733-740.
35. Liechtenstein, T., Dufait, I., Lanna, A., Breckpot, K. and Escors, D., Modulating co-stimulation during antigen presentation to enhance cancer immunotherapy. Immunol. Endocr. Metab. Agents Med. Chem. 2012. 12: 224-235.
36. Cejalvo, T., Sacedon, R., Hernandez-Lopez, C., Diez, B., Gutierrez-Frias, C., Valencia, J., Zapata, A. G. et al., Bone morphogenetic protein-2/4 signalling pathway components are expressed in the human thymus and inhibit early T-cell development. Immunology 2007. 121: 94-104.